NCT06319248 - MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial | Biotech Hunter

Enrollment

308

Participants

Timeline

Start Date

May 14, 2024

Primary Completion Date

May 30, 2029

Study Completion Date

July 30, 2029

Conditions

SepsisLow Blood Pressure

Interventions

DRUG

Midodrine

Subjects will receive standard of care for sepsis and 10 mg of Midodrine every 8 hours administered orally or enterally (via nasogastric tube)

OTHER

Standard of Care

Subjects will receive standard of care for sepsis treatment.

Trial Locations (1)

RECRUITING

Mayo Clinic Minnesota, Rochester